Literature DB >> 11385137

Antenatal dexamethasone administration impairs normal postnatal lung growth in rats.

S Okajima1, T Matsuda, K Cho, Y Matsumoto, Y Kobayashi, S Fujimoto.   

Abstract

Our purpose was to determine the influences of antenatal dexamethasone administration on neonatal lung development in rats. Dexamethasone (0.4 mg/kg maternal body weight per day) was administered i.p. on the 21st d (group 1) or on the 20th and 21st d (group 2) of gestation in Sprague Dawley rats with timed pregnancies. After natural deliveries, the lungs of the pups 1-60 d of age were removed and processed for morphometric analysis. In 60-d-old pups, groups 1 and 2 both showed a lower numerical density of alveoli and a larger mean alveolar radius than control pups. Antenatal administration of dexamethasone to rats impairs the normal postnatal lung growth. Some aspects of the use of antenatal glucocorticoid therapy in humans may require reconsideration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385137     DOI: 10.1203/00006450-200106000-00011

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Antenatal corticosteriods decrease forced vital capacity in infants born fullterm.

Authors:  Anuja Bandyopadhyay; James E Slaven; Cindy Evrard; Christina Tiller; David M Haas; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2020-07-08

2.  Retinoic acid combined with vitamin A synergizes to increase retinyl ester storage in the lungs of newborn and dexamethasone-treated neonatal rats.

Authors:  A Catharine Ross; Namasivayam Ambalavanan
Journal:  Neonatology       Date:  2007-02-23       Impact factor: 4.035

3.  Developmental Timing Determines the Protective Effect of Maternal Electroacupuncture on Perinatal Nicotine Exposure-Induced Offspring Lung Phenotype.

Authors:  Jian Dai; Bo Ji; Guozhen Zhao; Yawen Lu; Yitian Liu; Qiujie Mou; Reiko Sakurai; Yana Xie; Qin Zhang; Shuang Xu; Virender K Rehan
Journal:  Biomed Res Int       Date:  2020-02-27       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.